PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 32 filers reported holding PHARMACYTE BIOTECH INC in Q2 2022. The put-call ratio across all filers is 6.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8 | -86.7% | 3 | -85.7% | 0.00% | – |
| Q2 2023 | $60 | -33.3% | 21 | -32.3% | 0.00% | – |
| Q1 2023 | $90 | -44.1% | 31 | -43.6% | 0.00% | – |
| Q4 2022 | $161 | – | 55 | +77.4% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 31 | -98.8% | 0.00% | – |
| Q2 2022 | $6,000 | -95.8% | 2,526 | -95.9% | 0.00% | – |
| Q1 2022 | $142,000 | -16.5% | 61,869 | -9.2% | 0.00% | – |
| Q4 2021 | $170,000 | +4150.0% | 68,133 | +4950.6% | 0.00% | – |
| Q3 2021 | $4,000 | – | 1,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,061,411 | $2,378,000 | 1.62% |
| Ayrton Capital LLC | 153,130 | $343,000 | 0.56% |
| Shay Capital LLC | 982,698 | $2,201,000 | 0.44% |
| EQUITEC PROPRIETARY MARKETS, LLC | 342,994 | $768,000 | 0.22% |
| FNY Investment Advisers, LLC | 15,290 | $34,000 | 0.02% |
| K2 PRINCIPAL FUND, L.P. | 91,095 | $204,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 26,200 | $59,000 | 0.00% |
| Aspire Private Capital, LLC | 800 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,758 | $3,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,734 | $4,000 | 0.00% |